GB Sciences Inc (GBLX) CEO Purchases $40,985.24 in Stock

GB Sciences Inc (OTCMKTS:GBLX) CEO John C. Poss bought 99,964 shares of the stock in a transaction that occurred on Wednesday, July 11th. The stock was acquired at an average price of $0.41 per share, for a total transaction of $40,985.24. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.

OTCMKTS:GBLX opened at $0.25 on Friday. GB Sciences Inc has a 52 week low of $0.21 and a 52 week high of $1.56.

WARNING: This report was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://sportsperspectives.com/2018/11/09/gb-sciences-inc-gblx-ceo-purchases-40985-24-in-stock.html.

About GB Sciences

GB Sciences, Inc focuses to be a technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for various ailments. The company is developing technologies in plant biology, cultivation and extraction techniques, which are combined with biotechnology; and plans to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies.

See Also: Put Option

Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply